gene synthesis Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service Premium The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach. Ansa Biotechnologies Closes $68M Series A Financing The University of California, Berkeley spinout plans to use the funding to accelerate development of its enzymatic DNA synthesis technology. Molecular Assemblies Extends Series A Financing Round by $11.8M The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund. Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector. DNA Script Preparing Launch of Benchtop Enzymatic Synthesizer for 'DNA on Demand' Premium The Syntax instrument, available later this year, will initially be able to make batches of 96 oligos of 60-mer length at a time with same-day turnaround. Feb 5, 2021 Twist Bioscience Reveals MRD Testing Applications, Regeneron Genotyping Project Premium Feb 4, 2021 Twist Bioscience Fiscal Q1 Revenues Grow 64 Percent; JP Morgan Downgrades to Underweight Jan 4, 2021 Evercore ISI Downgrades Twist Bioscience to In-Line Rating Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Nov 23, 2020 Twist Bioscience Plots Continued Growth With NGS Product Push Into Ag-Bio, Cancer Dx Premium Nov 23, 2020 Twist Bioscience Fiscal Q4 Revenues More Than Double Oct 20, 2020 SVB Leerink Initiates Coverage of Twist Bioscience With Market Perform Rating Aug 6, 2020 Twist Bioscience Q3 Revenues Grow 56 Percent Jul 29, 2020 France's DNA Script Extends Series B Financing Round to $89M Jun 4, 2020 Twist Bioscience Prices $100M Stock Offering May 21, 2020 Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab Premium May 7, 2020 Twist Bioscience Q2 Revenues Increase 42 Percent Mar 2, 2020 Evonetix Closes £23M Series B Financing Feb 19, 2020 Twist Bioscience Announces $100M Public Stock Offering Feb 7, 2020 With Agilent Litigation Gone, Twist Bioscience Sees Long-Term Growth in Biopharma, DNA Data Storage Premium Feb 6, 2020 Twist Bioscience Settles With Agilent, Reports 49 Percent Rise in Fiscal Q1 Revenues Feb 6, 2020 Twist Bioscience Shares Soar on Speculation of Lawsuit Settlement With Agilent Jan 13, 2020 Evonetix, Imec Collaborate on Silicon Chip Manufacturing for DNA Synthesis Dec 12, 2019 Twist Bioscience Teases Products for Liquid Biopsy Market, Biopharma Collaborations Premium Oct 10, 2019 Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry Premium Load More Breaking News Mainz Biomed to Initiate Pivotal US Clinical Study for Colorectal Cancer Early Detection Test Pacific Biosciences, Boston Children's Hospital to Collaborate on Rare Disease Variant Pilot Project Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Gut Microbiome Characteristics Tied to Depressive Symptoms in New Studies Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients The Scan Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan. Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus. Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities. Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.